cisplatin,atezolizumab
roche
['cisplatin', 'imvigor130', 'congrat']
congrats to and a. bamias for the important javelin-like analysis of imvigor130. retrospective, post-hoc analysis but significant data. no os difference, perhaps a signal in cisplatin-eligible (difference with javelin? ) #asco23 
Ασυνάρτητος και ημιτελής. Passionate and perfectionist. Med Onc with special love to Gyn Onc and prostate cancer.